By inducing TLR-4 dimerization with small-molecule agonists, downstream signaling pathways can be activated to generate a strong pro-inflammatory response to kill tumor cells, which may have important implications in anti-tumor immunity [41]. This evidence concerns the gene TLR4 and neoplasm.